JS Link Inc, formerly DNA Link Inc, is a Korea-based company mainly engaged in the genome analysis business. The Company mainly engages in the research and development of genome analysis services and personal genome analysis service products used for disease prevention, diagnosis, and treatment. The Company also mainly engages in the manufacture and sale of coronavirus disease 2019 (COVID-19) diagnostic kits. In addition, the Company engages in the research and development of â€˜Avatar Mouse,â€™ an anticancer drug efficacy evaluation system using the mouseâ€™s biological system.

Employees

Sector

Biotechnology & Medical Research

More about the company

Quotes

Date	Price	Change	Volume
14/09/26	₩30,100.00	-4.29%	93,584
11/09/26	₩31,450.00	-3.68%	95,238
10/09/26	₩32,650.00	-1.06%	157,361
09/09/26	₩33,000.00	+4.10%	123,912
08/09/26	₩31,700.00	-2.16%	216,410

End-of-day quote Korea S.E.

More quotes

End-of-day quote Korea S.E. 14/09/2026			5-day change	1st Jan Change
30,100.00 ^KRW	-4.29%		-10.42%	+68.63%

08-14	JS Link, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026	CI
07-29	JS Link, Inc. announced that it has received KRW 53.392992 billion in funding from Lynas Rare Earths Limited	CI

Market Cap	1,046B 776M 673M 635M 575M 1.08B 74.21B 1.09B 7.58B 2.92B 37.75B 2.92B 2.85B 120B	P/E 2024	-10.5x	P/E 2025	-29.7x
Enterprise Value	1,049B 778M 674M 637M 577M 1.08B 74.41B 1.09B 7.6B 2.92B 37.85B 2.93B 2.86B 120B	EV / Sales 2024	8.93x	EV / Sales 2025	29.6x
Free-Float	72.31%	Yield 2024 *	-	Yield 2025	-

08-14	JS Link, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026	CI
07-29	JS Link, Inc. announced that it has received KRW 53.392992 billion in funding from Lynas Rare Earths Limited	CI
07-07	REalloys Inc. and JS Link Inc. Sign Non-Binding Strategic Letter of Intent to Develop Fully Integrated North American Rare Earth Magnet Platform	CI
07-07	Australia's Lynas, South Korea's JS Link sign deal for Malaysia magnet factory	RE
07-06	Australia's Lynas signs deal with South Korea's JS Link to develop Malaysian magnet factory	RE
06-25	JS Link, Inc. announced that it has received KRW 30 billion in funding from Joosung Sea & Air Co. Ltd	CI
05-15	JS Link, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026	CI
05-12	JS Link, Inc. announced that it expects to receive KRW 5 billion in funding	CI
05-12	JS Link, Inc. announced that it expects to receive KRW 30 billion in funding	CI
03-23	JS Link, Inc. Reports Earnings Results for the Full Year Ended December 31, 2025	CI
02-02	JS Link, Inc. announced that it has received KRW 20.00000805 billion in funding from Orbitech Co., Ltd., Joosung Sea & Air Co. Ltd	CI
11-14	JS Link, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2025	CI
11-03	Malaysia PM says $142 million magnet plant to boost rare earth sector, state media reports	RE

1 day	-4.29%
1 week	-10.42%
Current month	-8.79%
1 month	-27.47%
3 months	-8.65%
6 months	-28.16%
Current year	+68.63%

JS Link, Inc. Share Price

Stocks

A127120

KR7127120004

Biotechnology & Medical Research

Valuation: JS Link, Inc.

Chart: JS Link, Inc.

Latest news: JS Link, Inc.

Press Releases: JS Link, Inc.

Quotes and Performance

Price Extremes

Managers and Directors: JS Link, Inc.

Latest insider transactions

Other Biotechnology & Medical Research

Financials

Company Profile

Quotes

1 week	29,950	34,050
1 month	29,300	41,400
Current year	16,230	49,900
1 year	13,860	49,900
3 years	1,775	49,900
5 years	1,775	49,900
10 years	1,775	49,900

Manager	Title	Age	Since
Jun-Young Lee CEO	Chief Executive Officer	58	22/08/2024
Cheol-Gu Sim CEO	Chief Executive Officer	47	19/10/2023
Kenji Gonishi PRN	Corporate Officer/Principal	58	22/08/2024

Director	Title	Age	Since
Cheol-Gu Sim BRD	Director/Board Member	47	19/10/2023
Jun-Young Lee BRD	Director/Board Member	58	22/08/2024
Kenji Gonishi BRD	Director/Board Member	58	22/08/2024

Date	Insider	Type	Quantity	% Market Cap.
19/11/25	Jin-soo Park	Buy	1,500	0.0047%
17/11/25	Jin-soo Park	Buy	5,000	0.0157%
04/11/25	Jin-soo Park	Buy	87,138	0.2742%

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
JS LINK, INC.	-4.29%	-10.42%	+73.29%	+702.67%	815M
LONZA GROUP AG	+0.56%	-5.82%	-2.45%	+9.99%	45.48B
REVOLUTION MEDICINES, INC.	+0.66%	-2.34%	+340.62%	+524.38%	43.68B
IQVIA HOLDINGS INC.	+1.49%	-0.78%	+41.90%	+22.65%	43.09B
BEONE MEDICINES AG	+2.11%	-1.24%	+9.09%	+76.85%	39.4B
CELLTRION, INC.	+0.34%	-4.94%	+9.34%	+40.23%	31.91B
ASCENDIS PHARMA A/S	+0.53%	-2.08%	-	-	17.31B
MEDPACE HOLDINGS, INC.	+1.34%	+0.70%	+21.35%	+111.39%	16.4B
EUROFINS SCIENTIFIC SE	+2.07%	-0.77%	+13.07%	+32.89%	14.24B
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.	-1.85%	-5.33%	+78.63%	+34.13%	13.28B
Average	+0.30%	-3.18%	+64.98%	+172.80%	26.56B
Weighted average by Cap.	+0.92%	-3.26%	+75.99%	+128.75%

	2024	2025
Net sales	15.91B 11.8M 10.23M 9.66M 8.75M 16.42M 1.13B 16.54M 115M 44.35M 574M 44.37M 43.38M 1.83B	19.32B 14.33M 12.42M 11.73M 10.62M 19.93M 1.37B 20.09M 140M 53.85M 697M 53.87M 52.68M 2.22B
Net income	-10.8B -8.01M -6.95M -6.56M -5.94M -11.15M -766M -11.23M -78.27M -30.12M -390M -30.13M -29.46M -1.24B	-16.45B -12.2M -10.57M -9.98M -9.04M -16.97M -1.17B -17.1M -119M -45.85M -593M -45.87M -44.85M -1.89B
Net Debt	14.39B 10.68M 9.25M 8.74M 7.92M 14.85M 1.02B 14.97M 104M 40.13M 519M 40.14M 39.25M 1.65B	2.88B 2.14M 1.85M 1.75M 1.58M 2.97M 204M 3M 20.88M 8.03M 104M 8.04M 7.86M 331M